Showing results (71-80 of 117) with videos related to
Sort By:
Pageof 12
Leukemia|March 9, 2017
Alloreactivity: the Janus-face of hematopoietic stem cell transplantationA Gratwohl, A Sureda, J Cornelissen, et al.Leukemia & Lymphoma|May 11, 2002
Survival and freedom from progression in autotransplant lymphoma patients is independent of stem cell source: further follow-up from the original randomised study to assess engraftmentP D Kottaridis, K Peggs, N Schmitz, et al.Bone Marrow Transplantation|September 15, 2015
Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMTT Ruutu, L C de Wreede, A van Biezen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphomaT J Smith, B E Hillner, N Schmitz, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 24, 2012
ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)M Ghielmini, U Vitolo, E Kimby, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 7, 2011
Autologous stem-cell transplantation in patients with mantle cell lymphoma beyond 65 years of age: a study from the European Group for Blood and Marrow Transplantation (EBMT)E Jantunen, C Canals, M Attal, et al.Blood Cancer Journal|July 30, 2016
Pretransplant NPM1 MRD levels predict outcome after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemiaS Kayser, A Benner, C Thiede, et al.Bone Marrow Transplantation|November 8, 2016
Impact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT)J R Passweg, H Baldomero, P Bader, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2016
Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationS Genadieva-Stavrik, A Boumendil, P Dreger, et al.Bone Marrow Transplantation|November 8, 2019
Autologous hematopoietic stem cell transplantation for relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the lymphoma working party (LWP) of the EBMTE Domingo-Domènech, A Boumendil, F Climent, et al.Pageof 12